Basically, we publish through this collaborative mechanism—which is basically, as I said, the clinicians, the private sector, and governments—what standards need to be worked on and when they need to be worked out. It's a very expensive process to get these standards.
What are these standards? They are messaging standards, data standards, so that two heterogeneous computer systems from different vendors can talk to each other. What we try to do first is if we can borrow the standards and adopt them from international standards, we do that. If we basically can adopt them but have to Canadianize them for such things as our postal code, we'll do that. If, on the other hand, we're ahead of the curve and nobody else has the standard, as they didn't in terms of the clinical drug information systems, we basically build them from scratch. But when we build them, we build them as international standards and encourage basically as many people as we can in the rest of the world to adopt those standards as well.